Fludarabine Modulates Immune Response and Extends In Vivo Survival of Adoptively Transferred CD8 T Cells in Patients with Metastatic Melanoma
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference31 articles.
1. Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells.;C Yee;Proc Natl Acad Sci U S A,2002
2. Phase I study of adoptive T-cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma.;A Mackensen;J Clin Oncol,2006
3. Detection and long-term in vivo monitoring of individual tumor-specific T cell clones in patients with metastatic melanoma.;J Michalek;J Immunol,2007
4. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells.;JT Tan;J Exp Med,2002
5. Multiple choices: regulation of memory CD8 T cell generation and homeostasis by interleukin (IL)-7 and IL-15. [letter; comment.].;M Prlic;Journal of Experimental Medicine,2002
Cited by 101 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The Role of the JAK–STAT Pathway in Childhood B-Cell Acute Lymphoblastic Leukemia;International Journal of Molecular Sciences;2024-06-21
2. Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells;Journal for ImmunoTherapy of Cancer;2024-06
3. Prognostic differences between carmustine, etoposide, cytarabine and melphalan (BEAM) and carmustine, etoposide, cytarabine, melphalan and fludarabine (BEAMF) regimens before autologous stem cell transplantation plus chimeric antigen receptor T therapy in patients with refractory/relapsed B-cell non-Hodgkin-lymphoma;Cytotherapy;2024-05
4. Is estimated exposure an accurate surrogate for measured fludarabine levels in patients with CAR T-cell therapy?;Blood Advances;2024-04-27
5. Potential role of immune cell therapy in gynecological cancer and future promises: a comprehensive review;Medical Oncology;2024-03-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3